Joanne Turner

Joanne Turner's Title

Joanne Turner serves as the Executive Vice President of Research, a role that places her at the forefront of scientific investigation and strategic planning within her organization. As an EVP of Research, Turner is responsible for overseeing the development and implementation of research initiatives, ensuring that they align with the organization's goals and objectives. Her leadership in this role signifies her expertise and dedication to advancing scientific knowledge, particularly in the areas she specializes in.

Joanne Turner's Education and Expertise

Joanne Turner holds a Ph.D., underscoring her deep academic background and expertise in her field. Her advanced education equips her with the necessary skills to lead complex research projects and contribute significant findings to the scientific community. Her scholarly background also enhances her ability to mentor upcoming scientists and researchers, fostering a culture of continuous learning and innovation within her team.

Joanne Turner's Role at the Interdisciplinary NexGen TB Research Advancement Center

Joanne Turner co-leads the Development Core of the Interdisciplinary NexGen TB Research Advancement Center (IN-TRAC). In this capacity, she plays a critical role in guiding the direction of TB research, focusing on innovative approaches to understand and combat tuberculosis. Her work at IN-TRAC involves collaborating with a diverse team of experts, ensuring that the research is interdisciplinary and comprehensive. This role highlights her leadership in tackling one of the most pressing health issues globally.

Joanne Turner's Research Focus

Joanne Turner's research primarily explores the link between infection and cancer, with a particular emphasis on developing preventative treatments. Her work aims to uncover the mechanisms by which infections can lead to cancer, thereby identifying potential intervention points to prevent such outcomes. This research is crucial as it addresses the underlying causes of cancer, offering hope for new preventative strategies that could significantly reduce the incidence of cancer related to infections.